October 9, 2026 – We are pleased to highlight an in-depth Q&A article published recently in Cell & Gene Therapy Insights featuring our Founder and CEO, Dr. Frank Borriello, in conversation with Commissioning Editor Abigail Pinchbeck. Titled “Harnessing multiple immune pathways to drive antitumor activity,” the interview explores the scientific foundation, therapeutic rationale, and manufacturing…